| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5693161 | European Urology | 2017 | 18 Pages |
Abstract
Seven sources of energy have been employed to selectively ablate discrete areas of prostate cancer. There is high evidence that focal therapy is safe and has low detrimental impact on continence and potency. The oncological outcome has yet to be evaluated against standard of care.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Massimo Valerio, Yannick Cerantola, Scott E. Eggener, Herbert Lepor, Thomas J. Polascik, Arnauld Villers, Mark Emberton,